Gyre Therapeutics, Inc. (GYRE)
4.555
-1.86
(-28.94%)
USD |
NASDAQ |
Oct 30, 16:00
4.64
+0.08
(+1.87%)
After-Hours: 20:00
Gyre Therapeutics Price : 4.555 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 6.27 | 6.30 | 4.515 | 4.555 | 394082.0 |
| Oct 29, 2026 | 6.86 | 6.985 | 6.37 | 6.41 | 185320.0 |
| Oct 28, 2026 | 6.53 | 7.10 | 6.33 | 7.09 | 125172.0 |
| Oct 27, 2026 | 6.10 | 6.55 | 6.01 | 6.53 | 126373.0 |
| Oct 26, 2026 | 5.77 | 6.100 | 5.77 | 6.07 | 93375.00 |
| Oct 23, 2026 | 5.85 | 5.90 | 5.70 | 5.85 | 151483.0 |
| Oct 22, 2026 | 5.91 | 6.00 | 5.80 | 5.86 | 66577.00 |
| Oct 21, 2026 | 6.21 | 6.21 | 5.86 | 5.90 | 131361.0 |
| Oct 20, 2026 | 6.08 | 6.34 | 6.08 | 6.17 | 242073.0 |
| Oct 19, 2026 | 6.10 | 6.240 | 6.05 | 6.09 | 119945.0 |
| Oct 16, 2026 | 6.41 | 6.431 | 6.04 | 6.08 | 142876.0 |
| Oct 15, 2026 | 6.51 | 6.65 | 6.40 | 6.40 | 108766.0 |
| Oct 14, 2026 | 6.70 | 6.751 | 6.442 | 6.47 | 162848.0 |
| Oct 13, 2026 | 6.89 | 6.92 | 6.71 | 6.71 | 85058.00 |
| Oct 12, 2026 | 7.00 | 7.065 | 6.85 | 6.865 | 81956.00 |
| Oct 09, 2026 | 6.80 | 7.09 | 6.76 | 7.04 | 76632.00 |
| Oct 08, 2026 | 7.04 | 7.04 | 6.74 | 6.76 | 82839.00 |
| Oct 07, 2026 | 7.03 | 7.145 | 6.99 | 7.04 | 99188.00 |
| Oct 06, 2026 | 7.42 | 7.42 | 7.01 | 7.08 | 133971.0 |
| Oct 05, 2026 | 7.17 | 7.43 | 7.086 | 7.35 | 181458.0 |
| Oct 02, 2026 | 7.09 | 7.35 | 7.08 | 7.11 | 163747.0 |
| Oct 01, 2026 | 7.35 | 7.38 | 7.00 | 7.00 | 139999.0 |
| Sep 30, 2026 | 7.32 | 7.38 | 7.13 | 7.33 | 159793.0 |
| Sep 29, 2026 | 7.52 | 7.735 | 7.31 | 7.32 | 115119.0 |
| Sep 28, 2026 | 7.35 | 7.56 | 7.30 | 7.49 | 137050.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Cytokinetics, Inc. | 62.99 |
| Incyte Corp. | 120.39 |
| ACADIA Pharmaceuticals, Inc. | 20.59 |
| Alnylam Pharmaceuticals, Inc. | 165.00 |
| Anika Therapeutics, Inc. | 20.95 |
Price Related Metrics
| PS Ratio | 3.692 |
| PEG Ratio | -0.0142 |
| Price to Book Value | 4.475 |
| Earnings Yield | -4.30% |
| Market Cap | 482.98M |
| PEGY Ratio | -0.0142 |